News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-05 11:54:3 am Dyne: H2 2024 Muscle Disease Data Could Boost Value SeekingAlpha
2024-03-05 4:30:0 am Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights GlobeNewswire
2024-03-01 9:0:41 pm CEO & President Joshua Brumm Sells 100,000 Shares of Dyne Therapeutics Inc (DYN) GuruFocus.com
2024-02-29 12:2:8 am 14 Stocks With Heavy Insider Buying In 2024 Insider Monkey
2024-02-14 1:15:0 pm Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference GlobeNewswire
2024-02-01 4:30:0 am Dyne Therapeutics to Present at February Investor Conferences GlobeNewswire
2024-01-26 8:1:33 pm Chief Business Officer Jonathan Mcneill Sells 20,000 Shares of Dyne Therapeutics Inc (DYN) GuruFocus.com
2024-01-22 7:14:30 pm 7 Speculative Stocks to Double Your Money THIS Year InvestorPlace
2024-01-14 5:52:56 am Institutional owners may ignore Dyne Therapeutics, Inc.'s (NASDAQ:DYN) recent US$56m market cap decline as longer-term profits stay in the green Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information